Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis

Abstract

A distinctive property of Hepatocyte Growth Factor (HGF) is its ability to induce differentiation of tubular structures from epithelial and endothelial cells (branching tubulogenesis). The HGF receptor directly activates PI3 kinase, Ras and STAT signalling pathways and phosphorylates the adaptator GRB2 Associated Binder-1 (Gab1). Gab1 is also phosphorylated in response to Epidermal Growth Factor (EGF) but is unable to induce tubule formation. Comparison of 32P-peptide maps of Gab1 from EGF- versus HGF-treated cells, demonstrates that the same sites are phosphorylated in vivo. However, while both EGF and HGF induce rapid tyrosine phosphorylation of Gab1 with a peak at 15 min, the phosphorylation persists for over 1 h, only in response to HGF. Nine tyrosines are phosphorylated by both receptors. Three of them (Y307, Y373, Y407) bind phospholipase C-γ (PLC-γ). Interestingly, the overexpression of a Gab1 mutant unable to bind PLC-γ (Gab1 Y307/373/407F) did not alter HGF-stimulated cell scattering, only partially reduced the growth stimulation but completely abolished HGF-mediated tubulogenesis. It is concluded that sustained recruitment of PLCγ to Gab1 plays an important role in branching tubulogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

DAG:

diacylglycerol

EGF:

epidermal growth factor

Gab1:

GRB2 associated binder-1

GRB-2:

growth factor receptor-bound protein 2

GST:

glutathione S-transferase

HGF:

hepatocyte growth factor

IP3:

inosotol-1,4,5 triphosphare

NGF:

nervous growth factor

p85:

the 85 kDa regulatory subunit of PI 3 kinase

PDGF:

platelet-derived growth factor

PI 3 kinase:

phosphoinositide 3 kinase

PLC:

phospholipase C

SH2:

Src homology 2

SHC:

Src homology/collagen

SHPTP:

SH2 containing Phosphotyrosine phosphatase

STAT:

signal transducer and activator of the transcription

References

  • Aharonov A, Passovoy DS and Herschman HR . 1978 J Supramol Struct 9: 41–45

  • Anderson D, Koch CA, Grey L, Ellis C, Moran MF and Pawson T . 1990 Science 250: 979–982

  • Bardelli A, Longati P, Gramaglia D, Stella MC and Comoglio PM . 1997a Oncogene 18: 3103–3111

  • Berridge MJ, Bootman MD and Lipp P . 1998 Nature 395: 645–648

  • Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C and Comoglio PM . 1998 Nature 391: 285–288

  • Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B and Clarkson B . 1997 Cell 88: 197–204

  • Dolmetsch RE, Xu K and Lewis RS . 1998 Nature 392: 933–936

  • Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR and Greenberg ME . 1997 Science 275: 661–665

  • Fournier TM, Kamikura D, Teng K and Park M . 1996 J Biol Chem 271: 22211–22217

  • Franke TF, Kaplan DR and Cantley LC . 1997 Cell 88: 435–437

  • Graziani A, Gramaglia D, Cantley LC and Comoglio PM . 1991 J Biol Chem 266: 22087–22090

  • Gu H, Pratt JC, Burakoff SJ and Neel BG . 1998 Mol Cell 26: 729–740

  • Gual P, Baron V, Lequoy V and Van Obberghen E . 1998 Endocrinology 139: 884–893

  • Hartmann G, Weidner KM, Schwarz H and Birchmeier W . 1994 J Biol Chem 269: 21936–21939

  • Helin K and Beguinot L . 1991 J Biol Chem 266: 8363–8368

  • Herbst R, Carroll PM, Allard JD, Schilling J, Raabe T and Simon MA . 1996 Cell 85: 899–909

  • Holgado-Madruga EM, Emlet DR, Moscatello DK, Godwin AK and Wong AJ . 1996 Nature 379: 560–564

  • Holgado-Madruga M, Moscatello DK, Emlet DR, Dieterich R and Wong AJ . 1997 Proc Natl Acad Sci USA 94: 12419–12424

  • Jones N and Dumont DJ . 1998 Oncogene 17: 1097–1108

  • Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G . 1997 Nature 385: 544–548

  • Khwaja A, Lehmann K, Marte BM and Downward JD . 1998 J Biol Chem 273: 18793–18801

  • Kim HK, Kim JW, Zilberstein A, Margolis B, Kim JG, Schlessinger J and Rhee SG . 1991 Cell 65: 435–441

  • Kochhar KS and Iyer AP . 1996 Cancer Lett 104: 163–169

  • Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J . 1997 Cell 89: 693–702

  • Kozu A, Kato Y, Shitara Y, Hanano M and Sugiyama Y . 1997 Pharm Res 14: 1228–1235

  • Lecoq-Lafon C, Verdier F, Fichelson S, Chretien S, Gisselbrecht S, Lacombe C and Mayeux P . 1999 Blood 93: 2578–2585

  • Lehr S, Kotzka J, Herkner A, Klein E, Siethoff C, Knebel B, Noelle V, Bruning JC, Klein HW, Meyer HE, Krone W and Muller-Wieland D . 1999 Biochemistry 38: 151–159

  • Lipp M and Niggl E . 1996 Prog Biophys Mol Biol 65: 265–296

  • Margolis B, Li N, Koch A, Mohammadi M, Hurwitz DR, Zilberstein A, Ullrich A, Pawson T and Schlessinger J . 1990 EMBO J 9: 4375–4380

  • Maroun CR, Holgado-Madruga M, Royal I, Naujokas MA, Fournier TM, Wong AJ and Park M . 1999 Mol Cell Biol 19: 1784–1799

  • Marshall CJ . 1995 Cell 80: 179–185

  • McIntyre BS, Birkenfeld HP and Sylvester PW . 1995 Cell Prolif 28: 45–56

  • Ming GL, Song HJ, Berninger B, Inagaki N, Tessier-Lavigne M and Poo MM . 1999 Neuron 23: 139–148

  • Mizuno K, Higuchi O, Tajima H, Yonemasu T and Nakamura T . 1993 J Biochem Tokyo 114: 96–102

  • Montesano R, Matsumoto K, Nakamura T and Orci L . 1991 Cell 67: 901–908

  • Naka D, Shimomura T, Yoshiyama Y, Sato M, Ishii T and Hara H . 1993 FEBS Lett 329: 147–152

  • Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK and Comoglio PM . 1991 Oncogene 6: 501–504

  • Nguyen L, Holgado-Madruga M, Maroun C, Fixman ED, Kamikura D, Fournier T, Charest A, Tremblay ML, Wong AJ and Park M . 1997 J Biol Chem 272: 20811–20819

  • Nishida K, Yoshida Y, Itoh M, Fukada T, Ohtani T, Shirogane T, Atsumi T, Takahashi-Tezuka M, Ishihara K, Hibi M and Hirano T . 1999 Blood 93: 1809–1816

  • Nishizuka Y . 1992 Science 258: 607–614

  • Noh DY, Shin SH and Rhee SG . 1995 Biochim Biophys Acta 1242: 99–113

  • Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto C, Pelicci PG and Comoglio PM . 1995 Oncogene 10: 1631–1638

  • Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM . 1994 Cell 77: 261–271

  • Ponzetto C, Zhen Z, Audero E, Maina F, Bardelli A, Basile ML, Giordano S, Narsimhan R and Comoglio PM . 1996 J Biol Chem 271: 14119–14123

  • Porter VA, Bonev AD, Knot HJ, Heppner T, Stevenson AS, Kleppisch T, Lederer WJ and Nelson MT . 1998 Am J Physiol 274: C1346–C1355

  • Raabe T, Riesgo-Escovar J, Liu X, Bausenwein BS, Deak P, Maroy P and Hafen E . 1996 Cell 85: 911–920

  • Ridley AJ, Comoglio PM and Hall A . 1995 Mol Cell Biol 15: 1110–1122

  • Rocchi S, Tartare-Deckert S, Mothe I and Van Obberghen E . 1995 Endocrinology 136: 5291–5297

  • Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ and Van Obberghen E . 1998 Mol Endocrinol 12: 914–923

  • Royal I, Fournier TM and Park M . 1997 J Cell Physiol 173: 196–201

  • Royal I and Park M . 1995 J Biol Chem 270: 27780–27787

  • Stoker M . 1989 J Cell Physiol 139: 565–569

  • Sun XJ, Crimmins DL, Myers MGJ, Miralpeix M and White MF . 1993 Mol Cell Biol 13: 7418–7428

  • Sun XJ, Pons S, Asano T, Myers MGJ, Glasheen E and White MF . 1996 J Biol Chem 271: 10583–10587

  • Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M and Hirano T . 1998 Mol Cell Biol 18: 4109–4117

  • Takaishi K, Sasaki T, Kato M, Yamochi W, Kuroda S, Nakamura T, Takeichi M and Takai Y . 1994 Oncogene 9: 273–279

  • Thackeray JR, Gaines PC, Ebert P and Carlson JR . 1998 Development 125: 5033–5042

  • Traverse S, Gomez N, Paterson H, Marshall C and Cohen P . 1992 Biochem J 288: 351–355

  • Wahl M and Carpenter G . 1991 Bioessays 13: 107–113

  • Wang Z, Gluck S, Zhang L and Moran MF . 1998 Mol Cell Biol 18: 590–597

  • Weidner KM, DiCesare S, Sachs M, Brinkmann V, Behrens J and Birchmeier W . 1996 Nature 384: 173–176

  • Yamanashi Y and Baltimore D . 1997 Cell 88: 205–211

  • Yenush L and White MF . 1997 Bioessays 19: 491–500

Download references

Acknowledgements

We are grateful to Dr W Birchmeier for mouse Gab1 cDNA, Dr PP Di Fiore for GST-PLCγ fusion proteins and Dr T Miki for pCEV29.1 plasmid. The excellent technical assistance of L Palmas, R Albano and G Petruccelli is gratefully acknowledged. We thank Antonella Cignetto for secretarial help and Elaine Wright for editing the manuscript. This work was supported by BIOMED EC grant no. BMH4-98-3852 to PM Comoglio. P Gual and TA Williams are supported by Marie Curie TMR fellowships.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gual, P., Giordano, S., Williams, T. et al. Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene 19, 1509–1518 (2000). https://doi.org/10.1038/sj.onc.1203514

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203514

Keywords

This article is cited by

Search

Quick links